Nasometin (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasometin, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children as directed by a healthcare professional.

GNH USA supplies Nasometin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasometin, a nasal corticosteroid, acts on inflammatory processes of the nasal mucosa to relieve symptoms of several upper‑airway conditions. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Nasal polyps: helps shrink polyps and improves nasal airflow. - Chronic rhinosinusitis with nasal polyps: decreases inflammation and polyp size, aiding symptom control.

Nasometin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation - Cough - Altered taste or bitter taste

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal passages

Before initiating therapy, consider the following safety measures. - Assess for active nasal infection: postpone use until infection resolves. - Recent nasal surgery or trauma: avoid until cleared by a surgeon. - Use lowest effective dose: limit sprays to prescribed amount. - Monitor for signs of adrenal suppression: especially with long‑term high‑dose therapy. - Pregnancy and lactation: evaluate risk‑benefit with a clinician. - Store at room temperature: keep in original pack, protect from moisture and direct sunlight.

Nasometin can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure. - Concurrent use of other nasal corticosteroids: raises risk of systemic effects. - Recent nasal surgery combined with decongestant sprays: may exacerbate mucosal irritation.

Moderate Interactions (Monitor Closely): - Systemic immunosuppressants: heightened infection risk. - Antifungal nasal agents: potential reduction in efficacy. - Herbal supplements such as St. John's wort: may lower corticosteroid activity.